CFAP44-AS1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, CFAP44-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated CFAP44-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher CFAP44-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CFAP44-AS1 expression acts as an unfavorable survival marker, although some lineages such as READ and OV show a favorable association.

KIRC, UCEC, and READ are the cancer types where CFAP44-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCOSMedianAll0.5550.695<.001117view →
UCECDFSMedianAll0.5530.752<.00194view →
READOSTertileII,III,IV0.8820.628.00153view →
OVDFSTertileIII,IV0.5510.471.01844view →
KIRPOSQuartileIII,IV0.6400.206.00640view →
BLCAOSQuartileIII,IV0.6450.467.00537view →
COADOSQuartileAll0.7110.855.01123view →
ACCOSQuartileIV0.2960.704.01514view →
THYMDFSQuartileII,III,IV0.4930.949.02413view →
MESODFSTertileIV0.1360.516.00112view →
ESCAOSTertileIII,IV0.6290.285.01012view →
BRCAOSQuartileIV0.8070.283.00412view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

CFAP44-AS1–KIRC (OS)

Kaplan–Meier survival curve for CFAP44-AS1 RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration